Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 19681 AL 19695

Learning from failure

Nat Rev Drug Discov. 2010 Jul;9(7):499. doi: 10.1038/nrd3222.

The monomer state of beta-amyloid: where the Alzheimer's disease protein meets physiology

Giuffrida ML, Caraci F, De Bona P, Pappalardo G, Nicoletti F, Rizzarelli E, Copani A.

Rev Neurosci. 2010;21(2):83-93. doi: 10.1515/revneuro.2010.21.2.83.

Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues

Obulesu M, Rao DM.

Int J Neurosci. 2010 Aug;120(8):531-7. doi: 10.3109/00207451003760080.

Yeast as a model for studying Alzheimer's disease

Bharadwaj P, Martins R, Macreadie I.

FEMS Yeast Res. 2010 Dec;10(8):961-9. doi: 10.1111/j.1567-1364.2010.00658.x.

Relative importance of patient disease indicators on informal care and caregiver burden in Alzheimer's disease

Bergvall N, Brinck P, Eek D, Gustavsson A, Wimo A, Winblad B, Jönsson L.

Int Psychogeriatr. 2011 Feb;23(1):73-85. doi: 10.1017/S1041610210000785. Epub 2010 Jul 12.

Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment

Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC; Alzheimer's Disease Neuroimaging Initiative investigators.

Neurobiol Aging. 2010 Aug;31(8):1452-62, 1462.e1-2. doi: 10.1016/j.neurobiolaging.2010.04.011.

Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans

Hua X, Hibar DP, Lee S, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2010 Aug;31(8):1463-80. doi: 10.1016/j.neurobiolaging.2010.04.033.

[Effect of compound Polygonum multiflorum extract on Alzheimer's disease]

Chen L, Huang J, Xue L.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Jun;35(6):612-5. doi: 10.3969/j.issn.1672-7347.2010.06.012.

Mitochondrial dysfunction and Alzheimer's disease

Maruszak A, Żekanowski C.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):320-30. doi: 10.1016/j.pnpbp.2010.07.004. Epub 2010 Jul 16.

Head circumference, atrophy, and cognition: implications for brain reserve in Alzheimer disease

Perneczky R, Wagenpfeil S, Lunetta KL, Cupples LA, Green RC, Decarli C, Farrer LA, Kurz A; MIRAGE Study Group.

Neurology. 2010 Jul 13;75(2):137-42. doi: 10.1212/WNL.0b013e3181e7ca97.

Molecular mechanisms of regeneration in Alzheimer's disease brain

Uchida Y.

Geriatr Gerontol Int. 2010 Jul;10 Suppl 1:S158-68. doi: 10.1111/j.1447-0594.2010.00607.x.

The turn formation at positions 22 and 23 in the 42-mer amyloid beta peptide: the emerging role in the pathogenesis of Alzheimer's disease

Murakami K, Masuda Y, Shirasawa T, Shimizu T, Irie K.

Geriatr Gerontol Int. 2010 Jul;10 Suppl 1:S169-79. doi: 10.1111/j.1447-0594.2010.00598.x.

Is elevated norepinephrine an etiological factor in some cases of Alzheimer's disease?

Fitzgerald PJ.

Curr Alzheimer Res. 2010 Sep;7(6):506-16. doi: 10.2174/156720510792231775.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias